Renal damage in patients with Type 2 diabetes: A strong predictor of mortality

Diabetic Medicine

Volumn 22, Issue 3, 2005, Pages 258-265

  Bo, Simona ^a,b   Ciccone, G ^b   Rosato, R ^b   Gancia, R ^a   Grassi, G ^a   Merletti, F ^b   Pagano, G F ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Co morbidity; Coronary artery disease; Mortality; Renal damage; Type 2 diabetes

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; CANCER; CAUSE OF DEATH; COMORBIDITY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; KIDNEY INJURY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PROGNOSIS; RISK FACTOR; SMOKING;

AGE FACTORS; AGED; BODY MASS INDEX; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ITALY; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SMOKING; SURVIVAL RATE;

EID: 14644395554     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01394.x     Document Type: Article

References (39)

1. Head J, Fuller JH. International variation in mortality among diabetic patients: the WHO Multinational Study Vascular Disease in Diabetics. Diabetologia 1990; 33: 477-481.
2. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the US population, 1971-93. Diabetes Care 1998; 21: 1138-1145.
3. Koskinen SV, Reunanen AR, Martelin TP, Valkonen T. Mortality in a large population-based cohort of patients with drug-treated diabetes mellitus. Am J Public Health 1998; 88: 765-770.
4. Gatling W, Tufail S, Mullee MA, Westacott TA, Hill RD. Mortality rates in diabetic patients from a community-based population compared to local age/sex matched controls. Diabet Med 1997; 14: 316-320.
5. Roper NA, Bilous RW, Kelly WF, Unwin NC, Connolly VM. Excess mortality in a population with diabetes and the impact of material deprivation. Br Med J 2001; 322: 1389-1393.
6. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001; 44: S14-S21.
7. Walters DP, Gatling W, Houston AC, Mullee MA, Julious SA. Mortality in diabetic subjects: an eleven-year follow-up of a community-based population. Diabet Med 1994; 11: 968-973.
8. Nilsson PM, Johansson SE, Sundquist J. Low educational status is a risk factor for mortality among diabetic people. Diabet Med 1998; 15: 213-219.
9. Florkowski CM, Scott RS, Moir CL, Graham PJ. Lipid but not glycaemic parameters predict total mortality from type 2 diabetes mellitus in Canterbury, New Zealand. Diabet Med 1998; 15: 386-392.
10. Bruno G, Merletti F, Boffetta P, Cavallo-Perin P, Bargero G, Gallone G et al. Impact of glycaemic control, hypertension and insulin treatment on general and cause-specific mortality: an Italian population-based cohort of type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1999; 42: 297-301.
11. Bourdel-Marchasson I, Dubroca B, Decamps A, Richard-Harston S, Emeriau JP, Dartigues JF. Five-year mortality in elderly French subjects from the PAQUID epidemiological survey: the burden of diabetes. Diabet Med 1998; 15: 830-835.
12. Brun E, Nelson RG, Bennett PH, Imperatore G, Zoppini G, Verlato G et al. Diabetes duration and cause-specific mortality in the Verona Diabetes Study. Diabetes Care 2000; 23: 1119-1123.
13. Muggeo M, Verlato G, Bonora E, Zoppini G, Corbellini M, De Marco R. Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with noninsulin-dependent diabetes mellitus. Circulation 1997; 96: 1750-1754.
14. Andersson DKG, Svärdssudd K. Long-term glycemic control relates to mortality in type I diabetes. Diabetes Care 1995; 18: 1534-1543.
15. Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). Br Med J 2001; 322: 1-6.
16. Moss SE, Klein R, Klein BE, Meuer SM. The association of glycemia and cause-specific mortality in a diabetic population. Arch Intern Med 1994; 154: 2473-2479.
17. Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H et al. Risk factors for myocardial infarction and death in newly detected NIDDM. The Diabetes Intervention study, 11-year follow-up. Diabetologia 1996; 39: 1577-1583.
18. Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett WC, Speizer FE et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women. Arch Intern Med 2001; 161: 1717-1723.
19. Chaturvedi N, Jarrett J, Shipley MJ, Fuller JH. Socioeconomic gradient in morbidity and mortality in people with diabetes: cohort study finding from the Whitehall Study and the WHO Multinational Study of Vascular Disease in Diabetes. Br Med J 1998; 316: 100-105.
20. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G. A prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992; 41: 736-741.
21. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J. A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 1993; 16: 996-1003.
22. Niskanen LK, Penttila I, Parviainen M, Uusitupa MI. Evolution, risk factors and prognostic implications of albuminuria in NIDDM. Diabetes Care 1996; 19: 486-493.
23. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. Arch Intern Med 1997; 157: 1413-1418.
24. Morrish NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H. A prospective study of mortality among middle-aged diabetic patients (the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics) II. Associated risk factors. Diabetologia 1990; 33: 542-548.
25. Stephenson JM, Kenny S, Stevens LK, Fuller JH, Lee E and the WHO Multinational Study Group. Proteinuria and mortality in diabetes: the WHO Multinational Study of Vascular Disease in Diabetes. Diabet Med 1995; 12: 149-155.
26. Valmadrid CT, Klein R, Moss SE, Klein BEK. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 2000; 160: 1093-1100.
27. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310: 356-360.
28. Stiegler H, Standl E, Schulz K, Roth R, Lehmacher W. Morbidity, mortality, and albuminuria in type 2 diabetic patients: a three-year prospective study of a random cohort in general practice. Diabet Med 1992; 9: 646-653.
29. Nelson RG, Pettitt DJ, Carraher MJ, Baird HR, Knowler WC. Effect of proteinuria on mortality in NIDDM. Diabetes 1988; 37: 1499-1504.
30. Chan JCN, Cheung CK, Cheung MYF, Swaminathan R, Critchley JAJH, Cockram CS. Abnormal albuminuria as a predictor of mortality and renal impairment in Chinese patients with NIDDM. Diabetes Care 1995; 18: 1013-1016.
31. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003; 26: S5-S20.
32. Abraira C, Emanuele N, Colwell J, Henderson W, Comstock J, Levin S et al. Glycemic control and complications in type II diabetes: design of a feasibility trial. Diabetes Care 1992; 15: 1560-1571.
33. Retinopathy Working Party. A protocol for screening for diabetic retinopathy in Europe. Diabet Med 1991; 8: 263-267.
34. Biderman A, Rosenblatt I, Rosen S, Zangwill LM, Shalev R, Friger M et al. Sex differentials in predictors of mortality for patients with adult-onset diabetes. Diabetes Care 2000; 23: 602-605.
35. Östgren CJ, Lindblad U, Melander A, Råstam L. Survival in patients with type 2 diabetes in a Swedish community. Diabetes Care 2002; 25: 1297-1302.
36. Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Proteinuria predicts stroke and other atherosclerotic vascular disease events in non-diabetic and non-insulin-dependent diabetic subjects. Stroke 1996; 27: 2033-2039.
37. Fuller JH, Stevens LK, Wang SL and the WHO Multinational Study Group. Risk factors for cardiovascular mortality and morbidity: the WHO multinational study of vascular disease in diabetes. Diabetologia 200; 44: S54-S64.
38. Katamura M, Naka M, Kondo T, Nishii N, Komatsu M, Sato Y et al. Prospective analysis of mortality, morbidity, and risk factors in elderly diabetic subjects. Diabetes Care 2003; 26: 638-644.
39. Zoppini G, Verlato G, Bonora E, Muggeo M. Attending the diabetes center is associated with reduced cardiovascular mortality in type 2 diabetic patients: the Verona Diabetes Study. Diabetes Metab Res Rev 1999; 15: 170-174.